NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Micro Focus International plc (NYSE:MFGP)
Lead Plaintiff Deadline: July 23, 2018
Class Period: September 1, 2017 – March 19, 2018, and August 4, 2017 or August 22, 2017

Allegations: The Registration Statement and Prospectus filed for the Company’s Initial Public Offering contained materially false and misleading information and/or failed to disclose material information, and Micro Focus made materially false and misleading statements and/or failed to disclose material information throughout the class period.

Get additional information:

Aegean Marine Petroleum Network Inc. (NYSE:ANW)
Lead Plaintiff Deadline: August 6, 2018      
Class Period: April 28, 2016 - June 4, 2018

Allegations: Aegean had improperly accounted for an approximate $200 million of accounts receivable as of December 31, 2017; Aegean failed to maintain effective internal control over financial reporting; and as a result of the foregoing, Defendants’ statements about Aegean’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

Get additional information:

Deutsche Bank Aktiengesellschaft (NYSE:DB)
Lead Plaintiff Deadline: August 6, 2018
Class Period: March 20, 2017 - March 30, 2018

Allegations: Deutsche Bank made materially false and/or misleading statements or failed to disclose that: Deutsche Bank’s internal control environment and infrastructure were materially weak and deficient; and as a result, Deutsche Bank's statements about the Company's business and operations were materially false and misleading at all relevant times.

Get additional information:

Newell Brands Inc. (NYSE:NWL)
Lead Plaintiff Deadline: August 20, 2018
Class Period: February 6, 2017 - January 24, 2018

Allegations: The Company’s retail channel was loaded with extremely high levels of unsold Newell product; contrary to defendants’ representations, the build-up of Newell inventory in the retail channel was due to Company-specific rather than macroeconomic reasons; as a result of the unusually high levels of unsold inventory in the retail channel, Newell was exposed to a heightened risk that it would experience slower sales growth in future periods; and undisclosed managerial and cultural differences in the legacy Newell and Jarden businesses had created significant discord that was having a material adverse effect on the Company’s operating performance.

Get additional information:

Flex Pharma, Inc. (NASDAQ:FLKS)
Lead Plaintiff Deadline: August 20, 2018
Class Period: November 6, 2017 - June 12, 2018

Allegations: The Company overstated the viability and approval prospects for its product candidate FLX-787 for the treatment of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease; and as a result, Flex Pharma's public statements were materially false and misleading at all relevant times.

Get additional information:

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665